Actively Recruiting
Initial Standardized Global Review in Axial Spondyloarthritis
Led by Association de Recherche Clinique en Rhumatologie · Updated on 2025-08-26
154
Participants Needed
21
Research Sites
102 weeks
Total Duration
On this page
Sponsors
A
Association de Recherche Clinique en Rhumatologie
Lead Sponsor
R
RCTs
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study will be a pragmatic, cluster-randomized, controlled study with two parallel arms ( 'intervention' and 'usual care' (UC) arms) of one year duration. The study will be open-label, but centers randomized in the UC arm will not be aware of the intervention performed in the 'intervention' centers. The primary objective of this study will be to determine whether participation in a standardized global review (that includes assessment of disease domains and education ) as soon as possible after diagnosis of axial spondyloarthritis has a beneficial impact on patient knowledge of the disease at 12 months. The primary endpoint will be the change in the SPAKE (SPondyloArthritis Knowledge Questionnaire) questionnaire between M0 and M12.
CONDITIONS
Official Title
Initial Standardized Global Review in Axial Spondyloarthritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults under 80 years old
- Diagnosed with axial spondyloarthritis within 12 months before the baseline visit
- Ability to complete all study activities
- Completed informed consent
You will not qualify if you...
- Previous or planned participation in a dedicated education or global evaluation program for the disease within 12 months
- Physical or mental conditions affecting understanding or treatment adherence (e.g., major depression or substance/alcohol use)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 21 locations
1
CHU Besançon - Hôpital Jean Minjoz
Besançon, France
Not Yet Recruiting
2
CHU Bordeaux - Hôpital Pellegrin
Bordeaux, France
Not Yet Recruiting
3
CHRU Brest - Hôpital de La Cavale Blanche
Brest, France
Not Yet Recruiting
4
CHU Caen
Caen, France
Actively Recruiting
5
CHU Clermont-Ferrand - Hôpital Gabriel-Montpied
Clermont-Ferrand, France
Active, Not Recruiting
6
AP-HP - Hôpital Henri Mondor
Créteil, France
Actively Recruiting
7
CHD Vendée
La Roche-sur-Yon, France
Active, Not Recruiting
8
AP-HP - Hôpital Bicêtre
Le Kremlin-Bicêtre, France
Actively Recruiting
9
CH Le Mans
Le Mans, France
Active, Not Recruiting
10
GHICL - Hôpital Saint Philibert
Lomme, France
Not Yet Recruiting
11
AP-HM - Hôpital St Marguerite
Marseille, France
Active, Not Recruiting
12
AP-HP - Hôpital Cochin
Paris, France
Actively Recruiting
13
AP-HP - Hôpital La Pitié Salpétrière
Paris, France
Actively Recruiting
14
AP-HP - Hôpital Lariboisière
Paris, France
Not Yet Recruiting
15
AP-HP - Hôpital Saint Antoine
Paris, France
Actively Recruiting
16
HCL - Hôpital Lyon Sud
Pierre-Bénite, France
Actively Recruiting
17
CHU Rouen - Hôpital Charles-Nicolle
Rouen, France
Actively Recruiting
18
CHU Saint Etienne - Hôpital Nord
Saint-Priest-en-Jarez, France
Not Yet Recruiting
19
CHU Strasbourg - Hôpital de Hautepierre
Strasbourg, France
Actively Recruiting
20
Hopitaux de Toulouse (CHU) - Hôpital Pierre Paul Riquet
Toulouse, France
Actively Recruiting
21
CHU Tours - Hôpital Trousseau
Tours, France
Actively Recruiting
Research Team
A
Anna Molto
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here